Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
Xiaoqing Wu, Wenhua Tang, Rebecca T. Marquez, et al.
Oncotarget (2016) Vol. 7, Iss. 10, pp. 11708-11723
Open Access | Times Cited: 64

Showing 26-50 of 64 citing articles:

STAT3 inhibition reduced PD‐L1 expression and enhanced antitumor immune responses
Amirhossein Jahangiri, Maryam Dadmanesh, Khodayar Ghorban
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9457-9463
Closed Access | Times Cited: 33
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma
Federica Di Marco, Maria Concetta Cufaro, Verena Damiani, et al.
Oncogenesis (2025) Vol. 14, Iss. 1
Open Access
Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program
Elisabetta Stanzani, Fina Martínez‐Soler, Teresa Martín Mateos, et al.
Oncotarget (2017) Vol. 8, Iss. 43, pp. 73640-73653
Open Access | Times Cited: 39
Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains
Po‐Chang Shih
Life Sciences (2019) Vol. 242, pp. 117241-117241
Closed Access | Times Cited: 35
Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling
Qi Zhang, Zhe Yang, Xinbao Hao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma
Liangliang Wu, Yi Ge, Yudong Yuan, et al.
Cancer Letters (2022) Vol. 548, pp. 215864-215864
Closed Access | Times Cited: 15
Therapeutic potential of curcumin and its nanoformulations for treating oral cancer
Diptasree Mukherjee, Arunkumar Krishnan
World Journal of Methodology (2023) Vol. 13, Iss. 3, pp. 29-45
Open Access | Times Cited: 9
Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1
Jie Gao, Zhongjun Shao, Min Yan, et al.
Cancer Biomarkers (2018) Vol. 22, Iss. 4, pp. 641-648
Closed Access | Times Cited: 27
Impact of combination therapy with anti-PD-1 blockade and a STAT3 inhibitor on the tumor-infiltrating lymphocyte status
Tadashi Ashizawa, Akira Iizuka, Chie Maeda, et al.
Immunology Letters (2019) Vol. 216, pp. 43-50
Open Access | Times Cited: 25
CAIX Regulates GBM Motility and TAM Adhesion and Polarization through EGFR/STAT3 under Hypoxic Conditions
Bor‐Ren Huang, Yu‐Shu Liu, Sheng‐Wei Lai, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5838-5838
Open Access | Times Cited: 21
Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues
Adeoluwa A. Adeluola, Abu Hasanat Md. Zulfiker, Daniel A. Brazeau, et al.
European Journal of Pharmacology (2021) Vol. 906, pp. 174266-174266
Open Access | Times Cited: 19
Essential role of radiation therapy for the treatment of pancreatic cancer
Sophie Dobiasch, Nicole L. Goerig, Rainer Fietkau, et al.
Strahlentherapie und Onkologie (2017) Vol. 194, Iss. 3, pp. 185-195
Closed Access | Times Cited: 24
High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis
Lei Tang, Jinxia Liu, Zi-Juan Zhang, et al.
Pathology - Research and Practice (2019) Vol. 215, Iss. 6, pp. 152386-152386
Closed Access | Times Cited: 22
Low Intensity Focused Ultrasound (LOFU)-mediated Acoustic Immune Priming and Ablative Radiation Therapy for in situ Tumor Vaccines
Karin A. Skalina, Saurabh Singh, Claudia Gutierrez Chavez, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
Hai Yang, Bin Liu, Dongxue Liu, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3152-3152
Open Access | Times Cited: 12
The pro-inflammatory cytokines IL-1β and IL-6 promote upregulation of the ST6GAL1 sialyltransferase in pancreatic cancer cells
Austin D. Silva, Jihye Hwang, Michael P. Marciel, et al.
Journal of Biological Chemistry (2024), pp. 107752-107752
Open Access | Times Cited: 2
Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells.
Xinyu Fan, Duo He, Chang-Bin Sheng, et al.
PubMed (2019) Vol. 11, Iss. 6, pp. 3543-3554
Closed Access | Times Cited: 18
The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer
Lily Nguyen, Daniela Schilling, Sophie Dobiasch, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3703-3703
Open Access | Times Cited: 18
Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy
Yi Zhang, Zheng Li, Ying Huang, et al.
Nanomedicine (2023) Vol. 18, Iss. 27, pp. 2081-2099
Closed Access | Times Cited: 5
Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells
Jesse M. Mast, Dan Tse, Kevin Shee, et al.
Cell Biochemistry and Biophysics (2019) Vol. 77, Iss. 2, pp. 109-119
Closed Access | Times Cited: 15
Detachment Activated CyPA/CD147 Induces Cancer Stem Cell Potential in Non-stem Breast Cancer Cells
Yao Meng, Xinyu Fan, Lijun Yang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 14
Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic Analysis of Pancreatic Cancer Cells
Svenja Wiechmann, Elena Saupp, Daniela Schilling, et al.
Molecular & Cellular Proteomics (2020) Vol. 19, Iss. 10, pp. 1649-1663
Open Access | Times Cited: 13
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
Hannah Flebbe, Melanie Spitzner, Philipp Enno Marquet, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1301-1301
Open Access | Times Cited: 7
Selaginellin B induces apoptosis and autophagy in pancreatic cancer cells via the JAK2/STAT3 signaling pathway.
Peng Chu, Shisheng Wang, Xinxing Zhu, et al.
American Journal of Translational Research (2020) Vol. 12, Iss. 11, pp. 7127-7143
Closed Access | Times Cited: 10
Deciphering epithelial-to-mesenchymal transition in pancreatic cancer
Creighton Friend, Parash Parajuli, Mohammed S. Razzaque, et al.
Advances in cancer research (2023), pp. 37-73
Closed Access | Times Cited: 3

Scroll to top